Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taihao Biological Pharmaceutical, officially known as Jiangxi Taihao Biological Pharmaceutical Co., Ltd., is a pharmaceutical manufacturing company based in Nanchang, China. As a subsidiary of the Taihao Group, it specializes in the research, development, and production of biochemical drugs, chemical pharmaceuticals, and modernized Traditional Chinese Medicines (TCM). The company's portfolio includes a variety of formulations such as injections, capsules, and tablets, with a particular focus on anti-infectives, antivirals, and cardiovascular health. Taihao operates multiple GMP-certified production lines and maintains a significant presence in the domestic Chinese healthcare market. Its business model integrates traditional pharmaceutical manufacturing with modern biotechnological research to address diverse therapeutic needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taihao Biological Pharmaceutical.